L-817,818, agonist for alternate peptide hormone somatostatin, displays equivalent capacity to downregulate caspase-3 and caspase-9 expression following ocular hypertension induction, subsequently attenuating RGC death (Zhang et al., 2021b). The gene discussed is CASP3; the disease is ocular hypertension.